NSF International likely will be tapped to develop a protocol for the US Food and Drug Administration that can be used to assess cosmetic ingredient aggregate exposure risks.
FDA posted a notice May 16 to the US Federal Business Opportunities website (fbo.gov), stating its intention to procure...





